nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—hematologic cancer	0.244	1	CbGaD
Norfloxacin—TOP2A—Idarubicin—hematologic cancer	0.0526	0.0979	CbGbCtD
Norfloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0372	0.0693	CbGbCtD
Norfloxacin—TOP2A—Teniposide—hematologic cancer	0.0324	0.0602	CbGbCtD
Norfloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0226	0.0421	CbGbCtD
Norfloxacin—TOP2A—Epirubicin—hematologic cancer	0.0183	0.0341	CbGbCtD
Norfloxacin—CYP2A6—Methoxsalen—hematologic cancer	0.0164	0.0305	CbGbCtD
Norfloxacin—TOP2A—Etoposide—hematologic cancer	0.0143	0.0265	CbGbCtD
Norfloxacin—CYP1A2—Anagrelide—hematologic cancer	0.014	0.0261	CbGbCtD
Norfloxacin—CYP1A1—Methoxsalen—hematologic cancer	0.014	0.0261	CbGbCtD
Norfloxacin—CYP1A1—Bortezomib—hematologic cancer	0.0133	0.0248	CbGbCtD
Norfloxacin—CYP1A1—Daunorubicin—hematologic cancer	0.0128	0.0237	CbGbCtD
Norfloxacin—CYP2A6—Ifosfamide—hematologic cancer	0.012	0.0223	CbGbCtD
Norfloxacin—CYP1A1—Thalidomide—hematologic cancer	0.0116	0.0216	CbGbCtD
Norfloxacin—CYP1A1—Dacarbazine—hematologic cancer	0.00999	0.0186	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—hematologic cancer	0.00973	0.0181	CbGbCtD
Norfloxacin—CYP3A7—Ifosfamide—hematologic cancer	0.00818	0.0152	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00818	0.0152	CbGbCtD
Norfloxacin—CYP2A6—Prednisolone—hematologic cancer	0.00798	0.0148	CbGbCtD
Norfloxacin—CYP1A1—Dasatinib—hematologic cancer	0.00784	0.0146	CbGbCtD
Norfloxacin—CYP3A7—Imatinib—hematologic cancer	0.00781	0.0145	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00781	0.0145	CbGbCtD
Norfloxacin—CYP3A5—Daunorubicin—hematologic cancer	0.00765	0.0142	CbGbCtD
Norfloxacin—CYP1A2—Carmustine—hematologic cancer	0.00736	0.0137	CbGbCtD
Norfloxacin—CYP3A5—Thalidomide—hematologic cancer	0.00697	0.013	CbGbCtD
Norfloxacin—CYP3A5—Teniposide—hematologic cancer	0.00665	0.0124	CbGbCtD
Norfloxacin—CYP1A2—Methoxsalen—hematologic cancer	0.00626	0.0116	CbGbCtD
Norfloxacin—CYP3A5—Ifosfamide—hematologic cancer	0.00614	0.0114	CbGbCtD
Norfloxacin—CYP1A2—Bortezomib—hematologic cancer	0.00596	0.0111	CbGbCtD
Norfloxacin—CYP3A5—Imatinib—hematologic cancer	0.00586	0.0109	CbGbCtD
Norfloxacin—CYP1A2—Daunorubicin—hematologic cancer	0.0057	0.0106	CbGbCtD
Norfloxacin—CYP1A2—Alitretinoin—hematologic cancer	0.00558	0.0104	CbGbCtD
Norfloxacin—CYP1A2—Thalidomide—hematologic cancer	0.00519	0.00965	CbGbCtD
Norfloxacin—CYP3A4—Bexarotene—hematologic cancer	0.00509	0.00947	CbGbCtD
Norfloxacin—CYP3A7—Irinotecan—hematologic cancer	0.00488	0.00908	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00488	0.00908	CbGbCtD
Norfloxacin—CYP3A4—Busulfan—hematologic cancer	0.00473	0.0088	CbGbCtD
Norfloxacin—CYP3A4—Lomustine—hematologic cancer	0.00473	0.0088	CbGbCtD
Norfloxacin—CYP3A5—Dasatinib—hematologic cancer	0.00471	0.00876	CbGbCtD
Norfloxacin—CYP2A6—Dexamethasone—hematologic cancer	0.0047	0.00875	CbGbCtD
Norfloxacin—CYP1A2—Dacarbazine—hematologic cancer	0.00446	0.0083	CbGbCtD
Norfloxacin—CYP1A2—Imatinib—hematologic cancer	0.00436	0.00812	CbGbCtD
Norfloxacin—CYP3A7—Vincristine—hematologic cancer	0.00427	0.00794	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00427	0.00794	CbGbCtD
Norfloxacin—CYP3A4—Thiotepa—hematologic cancer	0.00422	0.00785	CbGbCtD
Norfloxacin—CYP1A1—Dexamethasone—hematologic cancer	0.00402	0.00747	CbGbCtD
Norfloxacin—CYP3A5—Irinotecan—hematologic cancer	0.00366	0.00681	CbGbCtD
Norfloxacin—CYP1A2—Dasatinib—hematologic cancer	0.0035	0.00652	CbGbCtD
Norfloxacin—CYP3A4—Methoxsalen—hematologic cancer	0.00328	0.0061	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00321	0.00598	CbGbCtD
Norfloxacin—CYP3A7—Dexamethasone—hematologic cancer	0.00321	0.00598	CbGbCtD
Norfloxacin—CYP3A5—Vincristine—hematologic cancer	0.0032	0.00595	CbGbCtD
Norfloxacin—CYP3A4—Bortezomib—hematologic cancer	0.00312	0.0058	CbGbCtD
Norfloxacin—CYP3A4—Daunorubicin—hematologic cancer	0.00298	0.00555	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—hematologic cancer	0.00293	0.00546	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—hematologic cancer	0.00283	0.00527	CbGbCtD
Norfloxacin—CYP3A4—Cytarabine—hematologic cancer	0.00263	0.0049	CbGbCtD
Norfloxacin—CYP3A4—Teniposide—hematologic cancer	0.00259	0.00482	CbGbCtD
Norfloxacin—CYP3A5—Dexamethasone—hematologic cancer	0.00241	0.00449	CbGbCtD
Norfloxacin—CYP3A4—Ifosfamide—hematologic cancer	0.00239	0.00445	CbGbCtD
Norfloxacin—CYP3A4—Imatinib—hematologic cancer	0.00229	0.00425	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—hematologic cancer	0.00218	0.00406	CbGbCtD
Norfloxacin—CYP3A4—Ruxolitinib—hematologic cancer	0.00215	0.004	CbGbCtD
Norfloxacin—CYP3A4—Nilotinib—hematologic cancer	0.00208	0.00386	CbGbCtD
Norfloxacin—CYP3A4—Vinorelbine—hematologic cancer	0.00206	0.00383	CbGbCtD
Norfloxacin—CYP3A4—Triamcinolone—hematologic cancer	0.00188	0.0035	CbGbCtD
Norfloxacin—CYP3A4—Dasatinib—hematologic cancer	0.00184	0.00342	CbGbCtD
Norfloxacin—CYP3A4—Mitoxantrone—hematologic cancer	0.00181	0.00337	CbGbCtD
Norfloxacin—CYP3A4—Betamethasone—hematologic cancer	0.00162	0.00301	CbGbCtD
Norfloxacin—CYP3A4—Prednisolone—hematologic cancer	0.00159	0.00297	CbGbCtD
Norfloxacin—CYP3A4—Prednisone—hematologic cancer	0.00151	0.0028	CbGbCtD
Norfloxacin—CYP3A4—Irinotecan—hematologic cancer	0.00143	0.00266	CbGbCtD
Norfloxacin—CYP3A4—Vinblastine—hematologic cancer	0.00127	0.00236	CbGbCtD
Norfloxacin—CYP3A4—Vincristine—hematologic cancer	0.00125	0.00232	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—hematologic cancer	0.00114	0.00213	CbGbCtD
Norfloxacin—CYP3A4—Dexamethasone—hematologic cancer	0.00094	0.00175	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—hematologic cancer	0.00078	0.00145	CbGbCtD
Norfloxacin—Trovafloxacin—TOP2A—hematologic cancer	0.000717	0.217	CrCbGaD
Norfloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.000543	0.164	CrCbGaD
Norfloxacin—Pefloxacin—TOP2A—hematologic cancer	0.000396	0.12	CrCbGaD
Norfloxacin—Enoxacin—TOP2A—hematologic cancer	0.000371	0.112	CrCbGaD
Norfloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000281	0.0849	CrCbGaD
Norfloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000247	0.0778	CbGdCrCtD
Norfloxacin—Levofloxacin—TOP2A—hematologic cancer	0.00024	0.0725	CrCbGaD
Norfloxacin—Ofloxacin—TOP2A—hematologic cancer	0.00024	0.0725	CrCbGaD
Norfloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000232	0.0701	CrCbGaD
Norfloxacin—Gatifloxacin—ALB—hematologic cancer	0.000156	0.0471	CrCbGaD
Norfloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000137	0.0431	CbGdCrCtD
Norfloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000136	0.0429	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000122	0.0386	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.000104	0.0327	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	9.78e-05	0.0308	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	9.78e-05	0.0308	CbGdCrCtD
Norfloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	9.43e-05	0.0297	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	9.25e-05	0.0291	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	9.25e-05	0.0291	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	9.25e-05	0.0291	CbGdCrCtD
Norfloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	7.86e-05	0.0248	CbGdCrCtD
Norfloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	7.14e-05	0.0225	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	7.01e-05	0.0221	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	7.01e-05	0.0221	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	7.01e-05	0.0221	CbGdCrCtD
Norfloxacin—Levofloxacin—ABCB1—hematologic cancer	6.83e-05	0.0206	CrCbGaD
Norfloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.6e-05	0.0208	CbGdCrCtD
Norfloxacin—Ciprofloxacin—ABCB1—hematologic cancer	6.6e-05	0.0199	CrCbGaD
Norfloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	6.36e-05	0.0201	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	6.17e-05	0.0195	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	6.17e-05	0.0195	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	6.17e-05	0.0194	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	6.17e-05	0.0194	CbGdCrCtD
Norfloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	5.98e-05	0.0189	CbGdCrCtD
Norfloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.68e-05	0.0179	CbGdCrCtD
Norfloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.53e-05	0.0174	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	5.31e-05	0.0167	CbGdCrCtD
Norfloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	5.28e-05	0.0166	CbGdCrCtD
Norfloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	5.01e-05	0.0158	CbGdCrCtD
Norfloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.71e-05	0.0148	CbGdCrCtD
Norfloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.67e-05	0.0147	CbGdCrCtD
Norfloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	4.32e-05	0.0136	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	4.25e-05	0.0134	CbGdCrCtD
Norfloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	4.08e-05	0.0129	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	4.03e-05	0.0127	CbGdCrCtD
Norfloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	3.97e-05	0.0125	CbGdCrCtD
Norfloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.78e-05	0.0119	CbGdCrCtD
Norfloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.67e-05	0.0116	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.59e-05	0.0113	CbGdCrCtD
Norfloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.47e-05	0.0109	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.37e-05	0.0106	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	3.22e-05	0.0101	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	3.22e-05	0.0101	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	3.22e-05	0.0101	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	2.98e-05	0.00938	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	2.98e-05	0.00938	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	2.98e-05	0.00938	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.63e-05	0.0083	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.49e-05	0.00784	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.49e-05	0.00784	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.42e-05	0.00764	CbGdCrCtD
Norfloxacin—Arthralgia—Prednisone—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Norfloxacin—Feeling abnormal—Triamcinolone—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Norfloxacin—Diarrhoea—Cisplatin—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Norfloxacin—Anxiety—Prednisone—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Norfloxacin—Vomiting—Gemcitabine—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Norfloxacin—Insomnia—Betamethasone—hematologic cancer	2.05e-05	0.000116	CcSEcCtD
Norfloxacin—Insomnia—Dexamethasone—hematologic cancer	2.05e-05	0.000116	CcSEcCtD
Norfloxacin—Paraesthesia—Betamethasone—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Norfloxacin—Paraesthesia—Dexamethasone—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Norfloxacin—Rash—Gemcitabine—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Norfloxacin—Dermatitis—Gemcitabine—hematologic cancer	2.03e-05	0.000115	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—hematologic cancer	2.03e-05	0.000115	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Norfloxacin—Headache—Gemcitabine—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Norfloxacin—Nausea—Vincristine—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—hematologic cancer	2.01e-05	0.000114	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisolone—hematologic cancer	2e-05	0.000114	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—hematologic cancer	2e-05	0.000114	CcSEcCtD
Norfloxacin—Dyspepsia—Dexamethasone—hematologic cancer	1.99e-05	0.000113	CcSEcCtD
Norfloxacin—Dyspepsia—Betamethasone—hematologic cancer	1.99e-05	0.000113	CcSEcCtD
Norfloxacin—Urticaria—Triamcinolone—hematologic cancer	1.98e-05	0.000113	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—hematologic cancer	1.98e-05	0.000112	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Body temperature increased—Triamcinolone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Oedema—Prednisone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Decreased appetite—Betamethasone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Decreased appetite—Dexamethasone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Nausea—Mitoxantrone—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Nausea—Irinotecan—hematologic cancer	1.97e-05	0.000112	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Norfloxacin—Fatigue—Betamethasone—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Norfloxacin—Fatigue—Dexamethasone—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Norfloxacin—Chills—Epirubicin—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Norfloxacin—Nausea—Gemcitabine—hematologic cancer	1.91e-05	0.000109	CcSEcCtD
Norfloxacin—Vomiting—Cisplatin—hematologic cancer	1.91e-05	0.000109	CcSEcCtD
Norfloxacin—Hyperhidrosis—Prednisone—hematologic cancer	1.91e-05	0.000108	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—hematologic cancer	1.9e-05	0.000108	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—hematologic cancer	1.9e-05	0.000108	CcSEcCtD
Norfloxacin—Rash—Cisplatin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Norfloxacin—Dermatitis—Cisplatin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—hematologic cancer	1.89e-05	0.000107	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Norfloxacin—Anorexia—Prednisone—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—hematologic cancer	1.87e-05	0.000107	CcSEcCtD
Norfloxacin—Feeling abnormal—Betamethasone—hematologic cancer	1.87e-05	0.000106	CcSEcCtD
Norfloxacin—Feeling abnormal—Dexamethasone—hematologic cancer	1.87e-05	0.000106	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—hematologic cancer	1.86e-05	0.000106	CcSEcCtD
Norfloxacin—Tension—Epirubicin—hematologic cancer	1.86e-05	0.000105	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Norfloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	1.84e-05	0.000105	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—hematologic cancer	1.84e-05	0.000104	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—hematologic cancer	1.83e-05	0.000104	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—hematologic cancer	1.82e-05	0.000103	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—hematologic cancer	1.82e-05	0.000103	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—hematologic cancer	1.8e-05	0.000103	CcSEcCtD
Norfloxacin—Urticaria—Dexamethasone—hematologic cancer	1.8e-05	0.000102	CcSEcCtD
Norfloxacin—Urticaria—Betamethasone—hematologic cancer	1.8e-05	0.000102	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.8e-05	0.000102	CcSEcCtD
Norfloxacin—Dizziness—Prednisolone—hematologic cancer	1.8e-05	0.000102	CcSEcCtD
Norfloxacin—Asthenia—Triamcinolone—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Norfloxacin—Body temperature increased—Dexamethasone—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Norfloxacin—Abdominal pain—Dexamethasone—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Norfloxacin—Body temperature increased—Betamethasone—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Norfloxacin—Abdominal pain—Betamethasone—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Norfloxacin—Nausea—Cisplatin—hematologic cancer	1.78e-05	0.000101	CcSEcCtD
Norfloxacin—Insomnia—Prednisone—hematologic cancer	1.78e-05	0.000101	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—hematologic cancer	1.78e-05	0.000101	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisone—hematologic cancer	1.77e-05	0.000101	CcSEcCtD
Norfloxacin—Pruritus—Triamcinolone—hematologic cancer	1.77e-05	0.0001	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—hematologic cancer	1.75e-05	9.95e-05	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—hematologic cancer	1.75e-05	9.95e-05	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—hematologic cancer	1.75e-05	9.94e-05	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—hematologic cancer	1.74e-05	9.88e-05	CcSEcCtD
Norfloxacin—Dyspepsia—Prednisone—hematologic cancer	1.74e-05	9.87e-05	CcSEcCtD
Norfloxacin—Rash—Etoposide—hematologic cancer	1.74e-05	9.87e-05	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—hematologic cancer	1.73e-05	9.86e-05	CcSEcCtD
Norfloxacin—Headache—Etoposide—hematologic cancer	1.72e-05	9.8e-05	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—hematologic cancer	1.72e-05	9.8e-05	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—hematologic cancer	1.72e-05	9.78e-05	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—hematologic cancer	1.72e-05	9.78e-05	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—hematologic cancer	1.72e-05	9.78e-05	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—hematologic cancer	1.72e-05	9.76e-05	CcSEcCtD
Norfloxacin—Decreased appetite—Prednisone—hematologic cancer	1.71e-05	9.75e-05	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—hematologic cancer	1.71e-05	9.74e-05	CcSEcCtD
Norfloxacin—Rash—Prednisolone—hematologic cancer	1.71e-05	9.73e-05	CcSEcCtD
Norfloxacin—Dermatitis—Prednisolone—hematologic cancer	1.71e-05	9.72e-05	CcSEcCtD
Norfloxacin—Fatigue—Prednisone—hematologic cancer	1.7e-05	9.67e-05	CcSEcCtD
Norfloxacin—Headache—Prednisolone—hematologic cancer	1.7e-05	9.67e-05	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—hematologic cancer	1.7e-05	9.66e-05	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—hematologic cancer	1.7e-05	9.66e-05	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—hematologic cancer	1.69e-05	9.62e-05	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—hematologic cancer	1.69e-05	9.62e-05	CcSEcCtD
Norfloxacin—Constipation—Prednisone—hematologic cancer	1.69e-05	9.59e-05	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—hematologic cancer	1.68e-05	9.56e-05	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—hematologic cancer	1.67e-05	9.5e-05	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—hematologic cancer	1.66e-05	9.45e-05	CcSEcCtD
Norfloxacin—Dizziness—Triamcinolone—hematologic cancer	1.65e-05	9.39e-05	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	1.65e-05	9.37e-05	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—hematologic cancer	1.65e-05	9.37e-05	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—hematologic cancer	1.64e-05	9.31e-05	CcSEcCtD
Norfloxacin—Nausea—Etoposide—hematologic cancer	1.63e-05	9.3e-05	CcSEcCtD
Norfloxacin—Feeling abnormal—Prednisone—hematologic cancer	1.63e-05	9.24e-05	CcSEcCtD
Norfloxacin—Asthenia—Betamethasone—hematologic cancer	1.63e-05	9.24e-05	CcSEcCtD
Norfloxacin—Asthenia—Dexamethasone—hematologic cancer	1.63e-05	9.24e-05	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	1.61e-05	9.18e-05	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	1.61e-05	9.17e-05	CcSEcCtD
Norfloxacin—Nausea—Prednisolone—hematologic cancer	1.61e-05	9.17e-05	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—hematologic cancer	1.61e-05	9.15e-05	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—hematologic cancer	1.61e-05	9.15e-05	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—hematologic cancer	1.61e-05	9.15e-05	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—hematologic cancer	1.61e-05	9.14e-05	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—hematologic cancer	1.6e-05	9.12e-05	CcSEcCtD
Norfloxacin—Pruritus—Dexamethasone—hematologic cancer	1.6e-05	9.11e-05	CcSEcCtD
Norfloxacin—Pruritus—Betamethasone—hematologic cancer	1.6e-05	9.11e-05	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	1.59e-05	9.06e-05	CcSEcCtD
Norfloxacin—Vomiting—Triamcinolone—hematologic cancer	1.59e-05	9.02e-05	CcSEcCtD
Norfloxacin—Rash—Triamcinolone—hematologic cancer	1.57e-05	8.95e-05	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—hematologic cancer	1.57e-05	8.95e-05	CcSEcCtD
Norfloxacin—Dermatitis—Triamcinolone—hematologic cancer	1.57e-05	8.94e-05	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—hematologic cancer	1.57e-05	8.93e-05	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—hematologic cancer	1.57e-05	8.93e-05	CcSEcCtD
Norfloxacin—Urticaria—Prednisone—hematologic cancer	1.57e-05	8.91e-05	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—hematologic cancer	1.57e-05	8.9e-05	CcSEcCtD
Norfloxacin—Headache—Triamcinolone—hematologic cancer	1.56e-05	8.89e-05	CcSEcCtD
Norfloxacin—Body temperature increased—Prednisone—hematologic cancer	1.56e-05	8.87e-05	CcSEcCtD
Norfloxacin—Abdominal pain—Prednisone—hematologic cancer	1.56e-05	8.87e-05	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—hematologic cancer	1.56e-05	8.84e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Dexamethasone—hematologic cancer	1.55e-05	8.81e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Betamethasone—hematologic cancer	1.55e-05	8.81e-05	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—hematologic cancer	1.55e-05	8.79e-05	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	1.54e-05	8.77e-05	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—hematologic cancer	1.54e-05	8.77e-05	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—hematologic cancer	1.52e-05	8.62e-05	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	1.51e-05	8.59e-05	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.5e-05	8.54e-05	CcSEcCtD
Norfloxacin—Dizziness—Dexamethasone—hematologic cancer	1.5e-05	8.52e-05	CcSEcCtD
Norfloxacin—Dizziness—Betamethasone—hematologic cancer	1.5e-05	8.52e-05	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	1.49e-05	8.48e-05	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—hematologic cancer	1.49e-05	8.48e-05	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.49e-05	0.00468	CbGdCrCtD
Norfloxacin—Anxiety—Doxorubicin—hematologic cancer	1.48e-05	8.44e-05	CcSEcCtD
Norfloxacin—Nausea—Triamcinolone—hematologic cancer	1.48e-05	8.43e-05	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—hematologic cancer	1.48e-05	8.42e-05	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—hematologic cancer	1.47e-05	8.36e-05	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—hematologic cancer	1.47e-05	8.36e-05	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—hematologic cancer	1.47e-05	8.33e-05	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—hematologic cancer	1.46e-05	8.28e-05	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisone—hematologic cancer	1.45e-05	8.26e-05	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—hematologic cancer	1.45e-05	8.25e-05	CcSEcCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.45e-05	0.00457	CbGdCrCtD
Norfloxacin—Vomiting—Betamethasone—hematologic cancer	1.44e-05	8.19e-05	CcSEcCtD
Norfloxacin—Vomiting—Dexamethasone—hematologic cancer	1.44e-05	8.19e-05	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—hematologic cancer	1.44e-05	8.18e-05	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—hematologic cancer	1.43e-05	8.15e-05	CcSEcCtD
Norfloxacin—Rash—Betamethasone—hematologic cancer	1.43e-05	8.12e-05	CcSEcCtD
Norfloxacin—Rash—Dexamethasone—hematologic cancer	1.43e-05	8.12e-05	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.43e-05	8.12e-05	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—hematologic cancer	1.43e-05	8.12e-05	CcSEcCtD
Norfloxacin—Dermatitis—Betamethasone—hematologic cancer	1.43e-05	8.11e-05	CcSEcCtD
Norfloxacin—Dermatitis—Dexamethasone—hematologic cancer	1.43e-05	8.11e-05	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—hematologic cancer	1.42e-05	8.08e-05	CcSEcCtD
Norfloxacin—Headache—Betamethasone—hematologic cancer	1.42e-05	8.07e-05	CcSEcCtD
Norfloxacin—Headache—Dexamethasone—hematologic cancer	1.42e-05	8.07e-05	CcSEcCtD
Norfloxacin—Asthenia—Prednisone—hematologic cancer	1.42e-05	8.05e-05	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.41e-05	7.99e-05	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.4e-05	7.95e-05	CcSEcCtD
Norfloxacin—Pruritus—Prednisone—hematologic cancer	1.4e-05	7.94e-05	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—hematologic cancer	1.4e-05	7.93e-05	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—hematologic cancer	1.39e-05	7.88e-05	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.38e-05	7.85e-05	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—hematologic cancer	1.38e-05	7.82e-05	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—hematologic cancer	1.37e-05	7.8e-05	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—hematologic cancer	1.36e-05	7.74e-05	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—hematologic cancer	1.36e-05	7.72e-05	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—hematologic cancer	1.36e-05	7.72e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Prednisone—hematologic cancer	1.35e-05	7.67e-05	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.35e-05	7.66e-05	CcSEcCtD
Norfloxacin—Nausea—Dexamethasone—hematologic cancer	1.35e-05	7.65e-05	CcSEcCtD
Norfloxacin—Nausea—Betamethasone—hematologic cancer	1.35e-05	7.65e-05	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—hematologic cancer	1.34e-05	7.63e-05	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—hematologic cancer	1.33e-05	7.56e-05	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—hematologic cancer	1.32e-05	7.5e-05	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—hematologic cancer	1.31e-05	7.45e-05	CcSEcCtD
Norfloxacin—Dizziness—Prednisone—hematologic cancer	1.3e-05	7.42e-05	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—hematologic cancer	1.3e-05	7.41e-05	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—hematologic cancer	1.3e-05	7.41e-05	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.3e-05	7.39e-05	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—hematologic cancer	1.29e-05	7.34e-05	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—hematologic cancer	1.28e-05	7.29e-05	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—hematologic cancer	1.27e-05	7.24e-05	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—hematologic cancer	1.27e-05	7.23e-05	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—hematologic cancer	1.27e-05	7.22e-05	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.26e-05	7.17e-05	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—hematologic cancer	1.26e-05	7.14e-05	CcSEcCtD
Norfloxacin—Vomiting—Prednisone—hematologic cancer	1.25e-05	7.13e-05	CcSEcCtD
Norfloxacin—Rash—Prednisone—hematologic cancer	1.24e-05	7.07e-05	CcSEcCtD
Norfloxacin—Dermatitis—Prednisone—hematologic cancer	1.24e-05	7.07e-05	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—hematologic cancer	1.24e-05	7.06e-05	CcSEcCtD
Norfloxacin—Headache—Prednisone—hematologic cancer	1.24e-05	7.03e-05	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—hematologic cancer	1.23e-05	7e-05	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—hematologic cancer	1.23e-05	6.97e-05	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—hematologic cancer	1.22e-05	6.94e-05	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—hematologic cancer	1.22e-05	6.93e-05	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—hematologic cancer	1.22e-05	6.93e-05	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—hematologic cancer	1.21e-05	6.91e-05	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—hematologic cancer	1.18e-05	6.73e-05	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	1.18e-05	6.69e-05	CcSEcCtD
Norfloxacin—Nausea—Prednisone—hematologic cancer	1.17e-05	6.66e-05	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.17e-05	6.64e-05	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—hematologic cancer	1.17e-05	6.63e-05	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—hematologic cancer	1.14e-05	6.46e-05	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—hematologic cancer	1.13e-05	6.45e-05	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—hematologic cancer	1.13e-05	6.42e-05	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—hematologic cancer	1.13e-05	6.42e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—hematologic cancer	1.13e-05	6.41e-05	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—hematologic cancer	1.11e-05	6.29e-05	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—hematologic cancer	1.09e-05	6.21e-05	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—hematologic cancer	1.09e-05	6.2e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—hematologic cancer	1.06e-05	6e-05	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	1.05e-05	5.98e-05	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—hematologic cancer	1.05e-05	5.96e-05	CcSEcCtD
Norfloxacin—Rash—Methotrexate—hematologic cancer	1.04e-05	5.91e-05	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—hematologic cancer	1.04e-05	5.9e-05	CcSEcCtD
Norfloxacin—Headache—Methotrexate—hematologic cancer	1.03e-05	5.87e-05	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—hematologic cancer	1.02e-05	5.82e-05	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—hematologic cancer	1.02e-05	5.8e-05	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—hematologic cancer	1.01e-05	5.74e-05	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—hematologic cancer	9.81e-06	5.58e-05	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—hematologic cancer	9.79e-06	5.57e-05	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—hematologic cancer	9.77e-06	5.55e-05	CcSEcCtD
Norfloxacin—Rash—Epirubicin—hematologic cancer	9.73e-06	5.53e-05	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—hematologic cancer	9.72e-06	5.53e-05	CcSEcCtD
Norfloxacin—Headache—Epirubicin—hematologic cancer	9.67e-06	5.5e-05	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—hematologic cancer	9.44e-06	5.37e-05	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—hematologic cancer	9.16e-06	5.21e-05	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—hematologic cancer	9.08e-06	5.16e-05	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—hematologic cancer	9e-06	5.12e-05	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—hematologic cancer	8.99e-06	5.11e-05	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—hematologic cancer	8.94e-06	5.08e-05	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—hematologic cancer	8.48e-06	4.82e-05	CcSEcCtD
Norfloxacin—CYP2A6—Metabolism—NUP214—hematologic cancer	7.11e-06	0.000195	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SDC1—hematologic cancer	7.06e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.06e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ARNTL—hematologic cancer	7.04e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTR—hematologic cancer	6.96e-06	0.000191	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCG2—hematologic cancer	6.96e-06	0.000191	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	6.91e-06	0.000189	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SMPD3—hematologic cancer	6.9e-06	0.000189	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA9—hematologic cancer	6.85e-06	0.000187	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ACP5—hematologic cancer	6.85e-06	0.000187	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ENO2—hematologic cancer	6.83e-06	0.000187	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—IDH1—hematologic cancer	6.81e-06	0.000187	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CDA—hematologic cancer	6.77e-06	0.000186	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOR2—hematologic cancer	6.76e-06	0.000185	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TXN—hematologic cancer	6.74e-06	0.000185	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTO1—hematologic cancer	6.74e-06	0.000185	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCC3—hematologic cancer	6.74e-06	0.000185	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—hematologic cancer	6.62e-06	0.000181	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SPHK1—hematologic cancer	6.59e-06	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PC—hematologic cancer	6.52e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SDC1—hematologic cancer	6.47e-06	0.000177	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—IDH1—hematologic cancer	6.44e-06	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCC3—hematologic cancer	6.36e-06	0.000174	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TXN—hematologic cancer	6.36e-06	0.000174	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTO1—hematologic cancer	6.36e-06	0.000174	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—UGT1A1—hematologic cancer	6.33e-06	0.000173	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GBA—hematologic cancer	6.3e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	6.3e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SPHK1—hematologic cancer	6.23e-06	0.000171	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC22A1—hematologic cancer	6.16e-06	0.000169	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CRABP1—hematologic cancer	6.16e-06	0.000169	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.03e-06	0.000165	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—DCK—hematologic cancer	6.03e-06	0.000165	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ASNS—hematologic cancer	6.03e-06	0.000165	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NQO1—hematologic cancer	6.01e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CD44—hematologic cancer	6.01e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALOX5—hematologic cancer	6e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—UGT1A1—hematologic cancer	5.98e-06	0.000164	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	5.95e-06	0.000163	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CRABP1—hematologic cancer	5.82e-06	0.000159	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC22A1—hematologic cancer	5.82e-06	0.000159	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NUP98—hematologic cancer	5.82e-06	0.000159	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTAP—hematologic cancer	5.76e-06	0.000158	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HDC—hematologic cancer	5.72e-06	0.000157	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYCS—hematologic cancer	5.68e-06	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALOX5—hematologic cancer	5.67e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	5.65e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADCY7—hematologic cancer	5.65e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NCOA3—hematologic cancer	5.65e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NUP214—hematologic cancer	5.61e-06	0.000154	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NQO1—hematologic cancer	5.5e-06	0.000151	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CD44—hematologic cancer	5.5e-06	0.000151	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NUP98—hematologic cancer	5.49e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCG2—hematologic cancer	5.49e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTR—hematologic cancer	5.49e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ENO2—hematologic cancer	5.39e-06	0.000147	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADCY7—hematologic cancer	5.33e-06	0.000146	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOA3—hematologic cancer	5.33e-06	0.000146	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NUP214—hematologic cancer	5.3e-06	0.000145	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.24e-06	0.000144	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CDA—hematologic cancer	5.23e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—hematologic cancer	5.22e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYCS—hematologic cancer	5.21e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTR—hematologic cancer	5.19e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCG2—hematologic cancer	5.19e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	5.18e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—FHL2—hematologic cancer	5.13e-06	0.000141	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SDC1—hematologic cancer	5.11e-06	0.00014	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ENO2—hematologic cancer	5.09e-06	0.000139	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AGRN—hematologic cancer	5.03e-06	0.000138	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PC—hematologic cancer	5.03e-06	0.000138	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTP1—hematologic cancer	5.01e-06	0.000137	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—hematologic cancer	4.93e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.86e-06	0.000133	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GBA—hematologic cancer	4.86e-06	0.000133	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.86e-06	0.000133	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SDC1—hematologic cancer	4.82e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH2—hematologic cancer	4.77e-06	0.000131	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMMR—hematologic cancer	4.77e-06	0.000131	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—hematologic cancer	4.74e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.61e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—hematologic cancer	4.6e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NCOR1—hematologic cancer	4.6e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—hematologic cancer	4.59e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.55e-06	0.000125	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.5e-06	0.000123	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.49e-06	0.000123	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTAP—hematologic cancer	4.45e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ACP5—hematologic cancer	4.36e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA9—hematologic cancer	4.36e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.35e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—hematologic cancer	4.35e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CD44—hematologic cancer	4.34e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NQO1—hematologic cancer	4.34e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.31e-06	0.000118	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—hematologic cancer	4.22e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NCOR1—hematologic cancer	4.22e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYCS—hematologic cancer	4.11e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH1—hematologic cancer	4.1e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CD44—hematologic cancer	4.1e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NQO1—hematologic cancer	4.1e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.08e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.07e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TXN—hematologic cancer	4.06e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.06e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.06e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.02e-06	0.00011	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.97e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—FHL2—hematologic cancer	3.96e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AGRN—hematologic cancer	3.89e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYCS—hematologic cancer	3.88e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	3.86e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.82e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—hematologic cancer	3.73e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.71e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.71e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMMR—hematologic cancer	3.68e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH2—hematologic cancer	3.68e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.62e-06	9.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.62e-06	9.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NUP98—hematologic cancer	3.5e-06	9.59e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.47e-06	9.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.46e-06	9.48e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.43e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—hematologic cancer	3.42e-06	9.37e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.42e-06	9.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.4e-06	9.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.4e-06	9.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NUP214—hematologic cancer	3.38e-06	9.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA9—hematologic cancer	3.37e-06	9.23e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACP5—hematologic cancer	3.37e-06	9.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.34e-06	9.15e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.33e-06	9.11e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.33e-06	9.11e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.32e-06	9.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.31e-06	9.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.31e-06	9.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTR—hematologic cancer	3.31e-06	9.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ENO2—hematologic cancer	3.24e-06	8.89e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—hematologic cancer	3.24e-06	8.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.17e-06	8.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.17e-06	8.67e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.15e-06	8.62e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—hematologic cancer	3.14e-06	8.61e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOR1—hematologic cancer	3.14e-06	8.61e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.13e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.13e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.13e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TXN—hematologic cancer	3.13e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.1e-06	8.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SDC1—hematologic cancer	3.08e-06	8.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.06e-06	8.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3e-06	8.23e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—hematologic cancer	2.97e-06	8.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.94e-06	8.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.94e-06	8.05e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.94e-06	8.05e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CREBBP—hematologic cancer	2.9e-06	7.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.9e-06	7.94e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.86e-06	7.85e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.86e-06	7.85e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.84e-06	7.77e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.79e-06	7.65e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.78e-06	7.61e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.77e-06	7.6e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CD—hematologic cancer	2.75e-06	7.54e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—hematologic cancer	2.72e-06	7.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.7e-06	7.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.62e-06	7.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.62e-06	7.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.62e-06	7.17e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NQO1—hematologic cancer	2.61e-06	7.16e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CD44—hematologic cancer	2.61e-06	7.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.61e-06	7.14e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3R1—hematologic cancer	2.6e-06	7.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.56e-06	7.01e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTR—hematologic cancer	2.55e-06	6.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.55e-06	6.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ENO2—hematologic cancer	2.5e-06	6.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYCS—hematologic cancer	2.47e-06	6.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.47e-06	6.77e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.46e-06	6.73e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.45e-06	6.7e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.43e-06	6.65e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.4e-06	6.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.37e-06	6.5e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.33e-06	6.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.29e-06	6.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—hematologic cancer	2.26e-06	6.2e-05	CbGpPWpGaD
Norfloxacin—TOP2A—blood—hematologic cancer	2.23e-06	0.0783	CbGeAlD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.21e-06	6.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.18e-06	5.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.17e-06	5.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.16e-06	5.93e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—EP300—hematologic cancer	2.16e-06	5.91e-05	CbGpPWpGaD
Norfloxacin—TOP2A—bone marrow—hematologic cancer	2.16e-06	0.0758	CbGeAlD
Norfloxacin—CYP3A5—Metabolism—ALB—hematologic cancer	2.14e-06	5.87e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.11e-06	5.78e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—hematologic cancer	2.07e-06	5.68e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.06e-06	5.65e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.05e-06	5.62e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.05e-06	5.62e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—hematologic cancer	2.03e-06	5.55e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CD44—hematologic cancer	2.02e-06	5.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.02e-06	5.53e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOR1—hematologic cancer	2e-06	5.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—hematologic cancer	2e-06	5.49e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—EP300—hematologic cancer	1.98e-06	5.42e-05	CbGpPWpGaD
Norfloxacin—TOP2A—lung—hematologic cancer	1.95e-06	0.0687	CbGeAlD
Norfloxacin—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.94e-06	5.31e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.91e-06	5.23e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.9e-06	5.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.89e-06	5.18e-05	CbGpPWpGaD
Norfloxacin—TOP2A—testis—hematologic cancer	1.84e-06	0.0648	CbGeAlD
Norfloxacin—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.79e-06	4.9e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—lung—hematologic cancer	1.78e-06	0.0627	CbGeAlD
Norfloxacin—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.77e-06	4.85e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.68e-06	4.61e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—hematologic cancer	1.64e-06	4.48e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—hematopoietic system—hematologic cancer	1.61e-06	0.0567	CbGeAlD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.6e-06	4.37e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.59e-06	4.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—hematopoietic system—hematologic cancer	1.59e-06	0.056	CbGeAlD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.56e-06	4.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—EP300—hematologic cancer	1.56e-06	4.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—hematopoietic system—hematologic cancer	1.56e-06	0.0547	CbGeAlD
Norfloxacin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.55e-06	4.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.55e-06	4.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—hematologic cancer	1.55e-06	4.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.49e-06	4.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EP300—hematologic cancer	1.47e-06	4.04e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.46e-06	4.01e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.38e-06	3.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.37e-06	3.74e-05	CbGpPWpGaD
Norfloxacin—TOP2A—lymph node—hematologic cancer	1.34e-06	0.047	CbGeAlD
Norfloxacin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.31e-06	3.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—hematologic cancer	1.3e-06	3.57e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—hematologic cancer	1.29e-06	3.54e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.24e-06	3.38e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—hematologic cancer	1.2e-06	3.27e-05	CbGpPWpGaD
Norfloxacin—SLC22A5—blood—hematologic cancer	1.18e-06	0.0415	CbGeAlD
Norfloxacin—CYP3A4—hematopoietic system—hematologic cancer	1.17e-06	0.0411	CbGeAlD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.15e-06	3.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.15e-06	3.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.14e-06	3.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.09e-06	2.99e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—blood—hematologic cancer	1.07e-06	0.0376	CbGeAlD
Norfloxacin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.06e-06	2.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—blood—hematologic cancer	1.05e-06	0.0371	CbGeAlD
Norfloxacin—SLC22A5—lung—hematologic cancer	1.03e-06	0.0364	CbGeAlD
Norfloxacin—CYP3A5—blood—hematologic cancer	1.03e-06	0.0362	CbGeAlD
Norfloxacin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.01e-06	2.77e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—hematologic cancer	9.97e-07	2.73e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—hematologic cancer	9.85e-07	2.7e-05	CbGpPWpGaD
Norfloxacin—SLC22A5—testis—hematologic cancer	9.76e-07	0.0343	CbGeAlD
Norfloxacin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.53e-07	2.61e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—hematologic cancer	9.43e-07	2.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EP300—hematologic cancer	9.4e-07	2.57e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—lung—hematologic cancer	9.37e-07	0.0329	CbGeAlD
Norfloxacin—CYP1A1—lung—hematologic cancer	9.24e-07	0.0325	CbGeAlD
Norfloxacin—CYP3A5—lung—hematologic cancer	9.04e-07	0.0318	CbGeAlD
Norfloxacin—CYP1A1—Metabolism—AKT1—hematologic cancer	8.91e-07	2.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.8e-07	2.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—blood—hematologic cancer	7.74e-07	0.0272	CbGeAlD
Norfloxacin—CYP3A4—Metabolism—PTEN—hematologic cancer	7.6e-07	2.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EP300—hematologic cancer	7.25e-07	1.99e-05	CbGpPWpGaD
Norfloxacin—SLC22A5—lymph node—hematologic cancer	7.07e-07	0.0249	CbGeAlD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.95e-07	1.9e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—lymph node—hematologic cancer	6.32e-07	0.0222	CbGeAlD
Norfloxacin—CYP1A2—Metabolism—AKT1—hematologic cancer	5.68e-07	1.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.36e-07	1.47e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—hematologic cancer	4.38e-07	1.2e-05	CbGpPWpGaD
